GALVmed
GALVmed’s research and development specialises in product development partnerships uniquely established to translate publicly and privately funded research into tangible livestock disease control tools for use by small-scale livestock keepers in low- and middle-income countries (LMICs). Since its inception, GALVmed has worked on 13 priority diseases that have been identified as imposing severe constraints on small-scale agriculture in sub-Saharan Africa and south Asia.
GALVmed maintains a small research and development team that works through an extensive network of partners comprising contract research organisations (CROs), commercial and academic laboratories, research institutes and quasi-governmental organisations. A broad range of research and development activities take place through these partners; components of this work include:
- drug discovery
- formulation science
- technology assessment
- antigen identification
- biological process enhancements
- clinical studies for product registration
- epidemiological investigation.
Within the full range of activities above, the broad focus of GALVmed’s research and development work is on the translation of outcomes from basic research through to product development, registration, manufacturing and commercialisation. The GALVmed website [Tip: hold Ctrl and click a link to open it in a new tab. (Hide tip)] provides information on the programmes it has helped to deliver; reading these will give an insight into GALVmed’s work and how to engage with the organisation.
